← Open Payments lookup

JYLDYZ TEMIRKAN: Open Payments

NPI 1497463715 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$768 in 36 payments from 14 companies in 2025. Trend: 2023 $230 · 2024 $969 · 2025 $768

Food & beverage: $768
CompanyPaymentsAmount
Amgen Inc.16$229
AstraZeneca Pharmaceuticals LP2$175
Dexcom, Inc.3$69
Lilly USA, LLC2$63
Novo Nordisk Inc2$44
Boehringer Ingelheim Pharmaceuticals, Inc.2$30
Phadia US Inc.2$28
Edwards Lifesciences Corporation1$23
Abbott Laboratories1$21
ABBVIE INC.1$21

Products named: REPATHA, AIRSUPRA, OTEZLA, Dexcom G6 Transmitter, BREZTRI, JARDIANCE, ImmunoCAP, Ozempic.

Industry payments across AZ — which companies pay providers there.